inVentiv Group Holdings IPO Research Information

inVentiv Group Holdings IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on inVentiv Group Holdings, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
inVentiv Group Holdings	INV - NYSE	Withdrawn	$0.00	$0.00	Withdrawn
Underwriter(s): Credit Suisse, Morgan Stanley, Goldman Sachs & Co., Jefferies
Co-Manager(s): Citigroup, BofA Merrill Lynch, Barclays, Wells Fargo, Baird, William Blair
Industry: Health Care
Filing(s): Filed 2016-04-05

About inVentiv Group Holdings (adapted from inVentiv Group Holdings prospectus):
They are a leading global provider of outsourced clinical development and commercialization services to biopharmaceutical companies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "INV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.